Financials

  • Market Capitalization 9.79 B
  • Employee 273
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-35.28
Relación precio/flujo de caja
106.17

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
909
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
78.51 USD-0.15%-1.78%+6.25%+98.03%9.99 B USD
921
PRAX
Praxis Precision Medicines, Inc. - Common Stock
350.58 USD+0.08%-4.16%+16.50%+677.34%9.79 B USD
942
PTGX
Protagonist Therapeutics, Inc. - Common Stock
146.69 USD-0.72%-3.90%+8.02%+95.25%9.49 B USD
959
PCVX
Vaxcyte, Inc. - Common Stock
61.06 USD+0.53%-1.82%+13.07%+44.35%9.09 B USD

Noticias